AMANDA BAINE: Open Payments
NPI 1528663275 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 79 payments from 21 companies in 2025. Trend: 2023 $1,250 · 2024 $1,033 · 2025 $1,347
Food & beverage: $1,347
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $213 |
| PFIZER INC. | 11 | $181 |
| AstraZeneca Pharmaceuticals LP | 10 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $126 |
| Amgen Inc. | 7 | $121 |
| ABBVIE INC. | 5 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| Esperion Therapeutics, Inc. | 2 | $36 |
Products named: NURTEC ODT, CAPLYTA, MOUNJARO, REXULTI, FARXIGA, AIRSUPRA, REPATHA, Kerendia.
Industry payments across AL — which companies pay providers there.
